Mirae Asset Global Investments Co., Ltd. Ironwood Pharmaceuticals Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 4,746 shares of IRWD stock, worth $21,451. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,746
Previous 94,683
94.99%
Holding current value
$21,451
Previous $824,000
96.36%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IRWD
# of Institutions
247Shares Held
171MCall Options Held
11.2MPut Options Held
28.5K-
Black Rock Inc. New York, NY22.9MShares$103 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA21.6MShares$97.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$74.1 Million18.04% of portfolio
-
State Street Corp Boston, MA9.24MShares$41.8 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA8.91MShares$40.3 Million0.15% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $693M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...